News
2d
News Medical on MSNFred Hutch leads new Vanguard Study for Cancer Screening Research NetworkFred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...
A new study reveals that rectal spacers during prostate cancer radiation therapy significantly reduce long-term erectile ...
1d
News Medical on MSN‘Fiery’ cell death during bladder cancer treatment may trigger chemo resistance by fueling cancer stem cellsChemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from ...
9don MSN
While radiation treatments designed to kill cancer cells have come a long way, scientists and doctors are always exploring ...
A new magnet array at Brookhaven Lab can steer cancer-killing proton beams at record energy levels up to 250 MeV. This magnet ...
The New Brunswick, N.J., pharmaceutical giant on Thursday said the application covers TAR-200 for the treatment of patients with Bacillus Calmette-Guerin-unresponsive high-risk non-muscle invasive ...
Every bladder cancer journey is different, and no single treatment or diagnostic path fits everyone. According to patients who have experienced bladder cancer, the best care for you will depend on ...
Discover a study that reveals a targetable CA125+ cell state in rare bladder cancer subtypes using single-cell RNA sequencing.
Hosted on MSN17d
Bladder cancer recurrence, urine acidity predictable ... - MSNHowever, bladder cancer is known to recur in about 40% of patients even after BCG treatment, raising the need to develop indicators that can predict the treatment response in advance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results